ArticlePhysics and imaging in radiation oncology2026
Development of an artificial intelligence driven dose prediction pipeline for online adaptive magnetic resonance-guided radiotherapy.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: The closed-off nature of most treatment planning systems (TPS) limits the potential for using artificial intelligence (AI) tools during online adaptive treatments. The aim of this study was to develop an AI-driven pipeline (AutoAdapt) for online planning of adaptive radiotherapy usable in a closed-off setting, providing optimal plan constraints derived from a population-based dose prediction model. Material and methods: The AutoAdapt pipeline consists of a physics-aware Swin UNet transformer network for dose prediction trained on 266 magnetic resonance images from 25 prostate cancer patients treated with 60 Gy on a 1.5 T magnetic resonance linear accelerator. The predicted dose was used to calculate plan constraints that were subsequently fed into a commercial TPS. AutoAdapt was tested using ten unseen cases and compared to manual plans based on clinical objectives, time, and complexity. Results: While all plans were approved by a radiation oncologist, AutoAdapt met all clinical objectives in seven patients compared to ten when manually planned. AutoAdapt yielded a significantly lower D Conclusions: The developed pipeline resulted in high-quality plans, ready for clinical use without further adjustments. AutoAdapt prioritized maximum rectum dose over D
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.